Comparison Partial Versus Total Omentectomy in Minimal Invasive Distal Gastrectomy for cT3/4a Gastric Cancer (KLASS-10)

For advanced gastric cancer, surgical resection is the only curable therapeutic strategy. According to minimally invasive approach is adopted in various field of oncologic surgery, laparoscopic gastrectomy with lymph node dissection is becoming a standard not only for early gastric cancer but also for advanced gastric cancer. The greater omentum is an organ is known to play a role in removing bacteria in the abdominal cavity as a primary defense. Complete resection of the greater omentum has been considered essential to ensure the elimination of micrometastasis during surgery for advanced gas

Trial Details

NCT ID
NCT06608381
Phase
PHASE3
Sponsor
Gangnam Severance Hospital
Status
RECRUITING
Cancer Type
Gastric Cancer
Interventions
  • Arm I (Total omentectomy),
  • Arm II (Partial omentectomy)
Locations (sample)
  • Seoul, South Korea|37.566,126.9784

Key Eligibility Criteria

  • Histologically proven adenocarcinoma of the stomach
  • Age between 20 to 85 years old
  • ECOG PS 0-1, ASA class I-III
  • Endoscopically Borrmann type I, II, III

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Gastric Cancer Trials on Trialify →